Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.
Proton-pump inhibitors (PPIs) seem to increase the incidence of cardiovascular events in patients with coronary artery disease (CAD), mainly in those using clopidogrel. We analysed the impact of PPIs on the prognosis of patients with stable CAD.We followed 706 patients with CAD. Primary outcome was...
Main Authors: | Ana María Pello Lázaro, Carmen Cristóbal, Juan Antonio Franco-Peláez, Nieves Tarín, Álvaro Aceña, Rocío Carda, Ana Huelmos, María Luisa Martín-Mariscal, Jesús Fuentes-Antras, Juan Martínez-Millá, Joaquín Alonso, Óscar Lorenzo, Jesús Egido, Lorenzo López-Bescós, José Tuñón |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5245803?pdf=render |
Similar Items
-
Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease.
by: José Tuñón, et al.
Published: (2014-01-01) -
N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease.
by: José Tuñón, et al.
Published: (2015-01-01) -
N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients
by: José Tuñón, et al.
Published: (2021-09-01) -
MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation
by: Luis M. Blanco-Colio, et al.
Published: (2021-03-01) -
Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients
by: Carlos Gutiérrez‐Landaluce, et al.
Published: (2021-08-01)